Miller Fisher syndrome is a rare, acute neurological disorder that is considered a variant of Guillain-Barré syndrome, characterized by the triad of ophthalmoplegia, ataxia, and areflexia. It is often associated with anti-GQ1b antibodies and typically follows a viral infection, with most patients experiencing a good prognosis and recovery over weeks to months.